β-D-Mannopyranuronic acid

Suppliers

Names

[ CAS No. ]:
9005-32-7

[ Name ]:
β-D-Mannopyranuronic acid

[Synonym ]:
β-D-Mannopyranuronic acid
MFCD00081309

Chemical & Physical Properties

[ Density]:
2.0±0.1 g/cm3

[ Boiling Point ]:
495.2±45.0 °C at 760 mmHg

[ Melting Point ]:
300 °C

[ Molecular Formula ]:
C₁₈H₂₆O₁₉

[ Molecular Weight ]:
194.139

[ Flash Point ]:
211.1±22.2 °C

[ Exact Mass ]:
194.042648

[ PSA ]:
127.45000

[ LogP ]:
-2.88

[ Appearance of Characters ]:
Powder | White to pale yellow to beige

[ Vapour Pressure ]:
0.0±2.9 mmHg at 25°C

[ Index of Refraction ]:
1.685

[ Water Solubility ]:
H2O: insoluble, but swells | Insoluble in water.

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
36/37/38

[ Safety Phrases ]:
24/25-36-26

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
2

[ RTECS ]:
AZ5775000

Articles

Safety and efficacy of ethylenediaminetetraacetic acid for removing microcapsules.

J. Surg. Res. 183(1) , 442-9, (2013)

Microencapsulated islets are used to prevent immune rejection associated with pancreatic islet transplantation, but cellular overgrowth affects transplantation success, necessitating removal of microc...

Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.

Pak. J. Pharm. Sci. 26(5) , 929-37, (2013)

The present study was performed to optimize the formulation of metoprolol succinate (MS) sustained release tablets using hydroxypropyl methylcellulose (HPMC) and sodium alginate (SA) as the matrix com...

Baicalein and hydroxypropyl-γ-cyclodextrin complex in poloxamer thermal sensitive hydrogel for vaginal administration.

Int. J. Pharm. 454(1) , 125-34, (2013)

The present study aimed to prepare a chemically and physically stable formulation of baicalein (Ba) in an in situ thermally sensitive hydrogel for vaginal administration. An inclusion complex of Ba an...

β-D-Mannopyranuronic acid, 4-O-β-D-mannopyranuronosyl-, potassium salt (1:2)
1-O-(dihydroxymethylsilyl)-beta-D-mannopyranuronic acid
(2S,3S,4S,5S)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid
β-D-Glucopyranosiduronic acid, 4-(1,1,3,3-tetramethylbutyl)phenyl
β-D-Glucopyranuronic acid, 1-[(αS)-α-methyl-4-(2-methylpropyl)benzeneacetate]
β-D-Glucopyranosiduronic acid, 2,3-dihydro-2,2-dimethyl-3-oxo-7-benzofuranyl
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
(4-Methyl-tetrahydro-furan-2-yl)-methanol
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
tert-Butyl-DL-alanine
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
N-[3-(Aminooxy)propyl]-N-butyl-1-butanamine